Association between body mass index and chronic kidney disease in men and women: Population-based study of Malay adults in Singapore

Nephrology Dialysis Transplantation

Volumn 23, Issue 6, 2008, Pages 1910-1918

  Shankar, Anoop ^a,e   Leng, Chenlei ^a   Chia, Kee Seng ^a   Koh, David ^a   Tai, E Shyong ^a   Saw, Seang Mei ^a,b   Lim, Su Chi ^a,c   Wong, Tien Yin ^b,d  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^c ALEXANDRA HOSPITAL   (Singapore)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

BMI; CKD; Kidney disease; Obese; Overweight

Indexed keywords

ADULT; AGED; ARTICLE; ASIAN; BODY MASS; CHRONIC KIDNEY DISEASE; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; SINGAPORE; STATISTICAL ANALYSIS;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CONFIDENCE INTERVALS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; PROBABILITY; RISK ASSESSMENT; SEX DISTRIBUTION; SINGAPORE;

EID: 44449179357     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm878     Document Type: Article

References (57)

1. US Renal Data System. USRDS Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2006
2. K/DOQI. Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(Suppl 1): S1-S266
3. Coresh J, Astor BC, Greene T et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12
4. Iseki K, Ikemiya Y, Fukiyama K. Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening. Kidney Int 1997; 51: 850-854
5. Lim YN, Lim TO. All renal replacement therapy in Malaysia. 14th Report of the Malaysian Dialysis and Transplant Registry, 2006, 1-3
6. Ogden CL, Carroll MD, Flegal KM. Epidemiologic trends in overweight and obesity. Endocrinol Metab Clin North Am 2003; 32: 741-760, vii
7. Cohen AH. Massive obesity and the kidney. A morphologic and statistical study. Am J Pathol 1975; 81: 117-130
8. Tozawa M, Iseki K, Iseki C et al. Influence of smoking and obesity on the development of proteinuria. Kidney Int 2002; 62: 956-962
9. Stengel B, Tarver-Carr ME, Powe NR et al. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology 2003; 14: 479-487
10. Iseki K, Ikemiya Y, Kinjo K et al. Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004; 65: 1870-1876
11. Hsu CY, McCulloch CE, Iribarren C et al. Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144: 21-28
12. Fox CS, Larson MG, Leip EP et al. Predictors of new-onset kidney disease in a community-based population. JAMA 2004; 291: 844-850
13. Pinto-Sietsma SJ, Navis G, Janssen WM et al. A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 2003; 41: 733-741
14. Kramer H, Luke A, Bidani A et al. Obesity and prevalent and incident CKD: the hypertension detection and follow-up program. Am J Kidney Dis 2005; 46: 587-594
15. Vupputuri S, Sandler DP. Lifestyle risk factors and chronic kidney disease. Ann Epidemiol 2003; 13: 712-720
16. Shankar A, Klein R, Klein BE. The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol 2006; 164: 263-271
17. Ejerblad E, Fored CM, Lindblad P et al. Association between smoking and chronic renal failure in a nationwide population-based case-control study. J Am Soc Nephrol 2004; 15: 2178-2185
18. Hallan S, de Mutsert R, Carlsen S et al. Obesity, smoking, and physical inactivity as risk factors for CKD: are men more vulnerable? Am J Kidney Dis 2006; 47: 396-405
19. Gelber RP, Kurth T, Kausz AT et al. Association between body mass index and CKD in apparently healthy men. Am J Kidney Dis 2005; 46: 871-880
20. Iseki K. Body mass index and the risk of chronic renal failure: the Asian experience. Contrib Nephrol 2006; 151: 42-56
21. Foong AW, Saw SM, Loo JL et al. Rationale and methodology for a population-based study of eye diseases in Malay people: The Singapore Malay Eye Study (SiMES). Ophthalmic Epidemiol 2007; 14: 25-35
22. Perloff D, Grim C, Flack J et al. Human blood pressure determination by sphygmomanometry. Circulation 1993; 88: 2460-2470
23. Chobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42: 1206-1252
24. Levey AS, Bosch JP, Lewis JB et al. (Modification of Diet in Renal Disease Study Group). A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-470
25. Figueiras A, Cadarso-Suarez C. Application of nonparametric models for calculating odds ratios and their confidence intervals for continuous exposures. Am J Epidemiol 2001; 154: 264-275
26. Hastie T, Tibshirani R. Generalized Additive Models, London: Chapman and Hall, 1990
27. Praga M, Hernandez E, Herrero JC et al. Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy. Kidney Int 2000; 58: 2111-2118
28. Porter LE, Hollenberg NK. Obesity, salt intake, and renal perfusion in healthy humans. Hypertension 1998; 32: 144-148
29. Hostetter TH, Olson JL, Rennke HG et al. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981; 241: F85-F93
30. Price DA, Lansang MC, Osei SY et al. Type 2 diabetes, obesity, and the renal response to blocking the renin system with irbesartan. Diabet Med 2002; 19: 858-861
31. Scaglione R, Ganguzza A, Corrao S et al. Central obesity and hypertension: pathophysiologic role of renal haemodynamics and function. Int J Obes Relat Metab Disord 1995; 19: 403-409
32. Ramkumar N, Cheung AK, Pappas LM et al. Association of obesity with inflammation in chronic kidney disease: a cross-sectional study. J Ren Nutr 2004; 14: 201-207
33. Lastra G, Manrique C, Sowers JR. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence. Adv Chronic Kidney Dis 2006; 13: 365-373
34. Annuk M, Soveri I, Zilmer M et al. Endothelial function, CRP and oxidative stress in chronic kidney disease. J Nephrol 2005; 18: 721-726
35. Chen J, Muntner P, Hamm LL et al. The metabolic syndrome and chronic kidney disease in U. S. adults. Ann Intern Med 2004; 140: 167-174
36. Chen J, Muntner P, Hamm LL et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol 2003; 14: 469-477
37. Gretz N, Zeier M, Geberth S et al. Is gender a determinant for evolution of renal failure? A study in autosomal dominant polycystic kidney disease. Am J Kidney Dis 1989; 14: 178-183
38. Hopper J, Jr, Trew PA, Biava CG. Membranous nephropathy: its relative benignity in women. Nephron 1981; 29: 18-24
39. Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol 2000; 11: 319-329
40. Zeier M, Gafter U, Ritz E. Renal function and renal disease in males or females - vive la petite difference. Nephrol Dial Transplant 1998; 13: 2195-2198
41. Silbiger SR, Neugarten J. The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 1995; 25: 515-533
42. Baylis C. Age-dependent glomerular damage in the rat. Dissociation between glomerular injury and both glomerular hypertension and hypertrophy. Male gender as a primary risk factor. J Clin Invest 1994; 94: 1823-1829
43. Remuzzi A, Puntorieri S, Mazzoleni A et al. Sex related differences in glomerular ultrafiltration and proteinuria in Munich-Wistar rats. Kidney Int 1988; 34: 481-486
44. Stringer KD, Komers R, Osman SA et al. Gender hormones and the progression of experimental polycystic kidney disease. Kidney Int 2005; 68: 1729-1739
45. Kwan G, Neugarten J, Sherman M et al. Effects of sex hormones on mesangial cell proliferation and collagen synthesis. Kidney Int 1996; 50: 1173-1179
46. Gandolfo MT, Verzola D, Salvatore F et al. Gender and the progression of chronic renal diseases: does apoptosis make the difference? Minerva Urol Nefrol 2004; 56: 1-14
47. Reckelhoff JF, Hennington BS, Moore AG et al. Gender differences in the renal nitric oxide (NO) system: dissociation between expression of endothelial NO synthase and renal hemodynamic response to NO synthase inhibition. Am J Hypertens 1998; 11: 97-104
48. Reckelhoff JF, Granger JP. Role of androgens in mediating hypertension and renal injury. Clin Exp Pharmacol Physiol 1999; 26: 127-131
49. Sandberg K, Ji H. Sex and the renin angiotensin system: implications for gender differences in the progression of kidney disease. Adv Ren Replace Ther 2003; 10: 15-23
50. Verzola D, Gandolfo MT, Salvatore F et al. Testosterone promotes apoptotic damage in human renal tubular cells. Kidney Int 2004; 65: 1252-1261
51. Kuk JL, Lee S, Heymsfield SB et al. Waist circumference and abdominal adipose tissue distribution: influence of age and sex. Am J Clin Nutr 2005; 81: 1330-1334
52. Horber FF, Gruber B, Thomi F et al. Effect of sex and age on bone mass, body composition and fuel metabolism in humans. Nutrition 1997; 13: 524-534
53. Wang J, Thornton JC, Russell M et al. Asians have lower body mass index (BMI) but higher percent body fat than do whites: comparisons of anthropometric measurements. Am J Clin Nutr 1994; 60: 23-28
54. Deurenberg-Yap M, Chew SK, Deurenberg P. Elevated body fat percentage and cardiovascular risks at low body mass index levels among Singaporean Chinese, Malays and Indians. Obes Rev 2002; 3: 209-215
55. Ramirez SP, McClellan W, Port FK et al. Risk factors for proteinuria in a large, multiracial, southeast Asian population. J Am Soc Nephrol 2002; 13: 1907-1917
56. Ahmed MH. Rimonabant as a potential new treatment for an emerging epidemic of obesity-related glomerulopathy? Expert Opin Emerg Drugs 2006; 11: 563-565
57. Nguyen S, Hsu CY. Excess weight as a risk factor for kidney failure. Curr Opin Nephrol Hypertens 2007; 16: 71-76